News

News

SGLT2 inhibitors and CKD-MBD

In a recent article co-authored by PHD center members: Daniel Hsiang-Te Tsai, Albert Tzu-Ming Chuang, Kuan-Hung Liu, Shih-Chieh Shao, and Edward Chia-Cheng Lai, they investigated the association between SGLT2 inhibitors and biochemical abnormalities related to CKD-MBD.

The study found that the use of SGLT2 inhibitors was associated with a lower incidence of CKD-MBD-related biochemical abnormalities compared to GLP-1 receptor agonists. These findings suggest that SGLT2 inhibitors may be considered to reduce the risk of CKD-MBD in patients with type 2 diabetes mellitus and stage 1–3 CKD.

SGLT2 inhibitors and CKD-MBD Read More »

Explore OCEAN platform and Lecture for the evolution of RWE

Our collaborative discussion with Dr. Ritchey to explore the framework for building the OCEAN platform. We were also happy to host her for an inspiring lecture, attended by faculty and members from the School of Pharmacy, School of Public Health, NCKU Hospital, and the College of Medicine. Her insights into epidemiology and the evolution of real-world evidence were truly invaluable.

Explore OCEAN platform and Lecture for the evolution of RWE Read More »

Research Fellow Michael Cheng received the Most Highly Rated Methods Award at the 40th ISPE Annual Meeting

Congratulations to Research Fellow Michael Chun-Yuan Cheng for Winning the Most Highly Rated Methods Award at the 40th ISPE Annual Meeting
Title of study: Immortal bias from different lengths of grace period in a clone-censor-weight design: a simulation study

Research Fellow Michael Cheng received the Most Highly Rated Methods Award at the 40th ISPE Annual Meeting Read More »